Russian state nanotechnology corporation “RosNano” will cooperate with American MP Biomedicals company in human life extension and ageing fight.
      
      The companies have signed an agreement on cooperation, which provided building new experimental facilities for development and production of pharmaceuticals in the field of individual pharmacogenetics (pharmacogenetics studies genetically determined reactions of an organism on various drugs).
      
      Russian and American scientists agreed to take part in scientific, coordination, expert and other boards in biotechnology and pharmacy, as well as support each other and provide safety during development and application of nanotechnologies.
      
      Cooperation is expected to result in long-term forecasts in nanotechnology applications in life sciences, pharmacy and related industries.
      
      Source: RIA Novosti